SNN
Smith & Nephew plc NYSE$30.90
Mkt Cap $13.2B
52w Low $27.97
27.1% of range
52w High $38.79
50d MA $33.36
200d MA $34.31
P/E (TTM)
21.3x
EV/EBITDA
10.8x
P/B
2.5x
Debt/Equity
0.6x
ROE
—
P/FCF
16.7x
RSI (14)
—
ATR (14)
—
Beta
0.74
50d MA
$33.36
200d MA
$34.31
Avg Volume
884.6K
About
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction pro…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | AMC | 1.16 | 1.18 | +1.7% | 35.76 | +1.3% | +2.8% | +1.7% | -2.5% | -4.1% | -4.7% | -10.3% | — |
| Aug 5, 2025 | AMC | 0.86 | 0.67 | -21.7% | 35.48 | +0.4% | +0.1% | +1.7% | +1.9% | +1.4% | +2.1% | +6.1% | — |
| Feb 25, 2025 | AMC | 0.92 | 0.23 | -75.5% | 28.11 | +2.7% | +2.9% | +3.1% | +3.0% | +5.5% | +6.7% | +1.1% | — |
| Oct 31, 2024 | AMC | 0.79 | 0.24 | -68.8% | 25.09 | +2.2% | +0.6% | +0.8% | +1.9% | -2.4% | -1.6% | +2.6% | — |
| Feb 27, 2024 | AMC | 0.97 | 0.05 | -94.6% | 27.96 | -3.4% | -5.5% | -5.2% | -5.5% | -5.2% | -4.8% | -9.3% | — |
| Aug 3, 2023 | AMC | 0.73 | 0.10 | -86.5% | 28.48 | +0.5% | +0.4% | +0.2% | -0.9% | -0.4% | -0.7% | -8.1% | — |
| Feb 28, 2023 | AMC | 0.73 | 0.03 | -96.4% | 28.57 | +1.5% | +0.4% | +0.7% | +2.9% | +1.2% | +0.7% | -4.2% | — |
| Jul 2, 2022 | AMC | 0.76 | 0.10 | -86.7% | — | — | — | — | — | — | — | — | — |
| Feb 24, 2022 | AMC | 0.87 | 0.18 | -79.1% | 34.26 | +0.9% | +3.9% | +4.0% | +1.9% | +2.8% | -0.9% | -4.9% | — |
| Jul 3, 2021 | AMC | 0.79 | 0.12 | -85.2% | — | — | — | — | — | — | — | — | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5 | Canaccord Genuity | Maintains | Hold → Hold | — | $36.36 | $34.87 | -4.1% | -4.2% | -5.6% | -6.3% | -9.0% | -8.3% |
| Nov 11 | Canaccord Genuity | Maintains | Hold → Hold | — | $33.35 | $33.10 | -0.7% | -0.2% | +0.4% | -1.1% | -2.0% | -2.3% |
| Oct 14 | Bernstein | Downgrade | Outperform → Market Perform | — | $35.21 | $34.74 | -1.3% | +0.1% | +0.5% | +1.7% | +3.2% | +3.2% |
| Aug 18 | Canaccord Genuity | Maintains | Hold → Hold | — | $36.20 | $36.64 | +1.2% | +0.2% | +1.9% | +3.3% | +2.1% | +3.6% |
| May 1 | Canaccord Genuity | Maintains | Hold → Hold | — | $28.02 | $28.29 | +1.0% | +0.7% | +2.1% | +1.2% | +1.5% | +1.1% |
| Mar 17 | Canaccord Genuity | Maintains | Hold → Hold | — | $28.57 | $28.75 | +0.6% | +1.6% | +0.7% | -0.6% | -0.4% | -1.5% |
| Mar 12 | UBS | Downgrade | Buy → Neutral | — | $29.84 | $28.81 | -3.5% | -3.4% | -5.5% | -4.3% | -2.7% | -3.6% |
| Feb 26 | Canaccord Genuity | Maintains | Hold → Hold | — | $28.11 | $28.86 | +2.7% | +2.9% | +3.1% | +3.0% | +5.5% | +6.7% |
| Jun 5 | UBS | Upgrade | Neutral → Buy | — | $25.51 | $26.18 | +2.6% | +2.9% | +3.8% | +3.3% | +2.5% | +1.1% |
| Oct 4 | Bernstein | Maintains | Outperform → Outperform | — | $23.75 | $23.89 | +0.6% | +0.0% | -0.9% | -0.2% | +0.1% | +0.9% |
Data updated apr 27, 2026 2:11am
· Source: massive.com